None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Healthy male and female subjects aged 5 14 years. No history of severe periodontal disease, recurrent oral infections, or advanced dental caries requiring medical intervention. No use of antibiotics, antifungal agents, or strong antiseptic mouthwashes within 30 days prior to study enrollment. Willing to maintain regular oral hygiene practices during the study.
Exclusion criteria
Exclusion criteria: History of severe oral disease requiring medical intervention. Use of antibiotics, antifungal agents, or strong antiseptic mouthwashes within 30 days before screening. Pregnant or lactating women. Known allergy to any ingredient in the Nutraceutical Formulation. Diagnosed gastrointestinal disorders that may interfere with probiotic absorption. Individuals currently enrolled in another clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in Streptococcus mutans and Lactobacillus acidophilus levels from baseline to Week 6.Timepoint: At Week 6 Last microbiota sampling will be done i.e at 3rd follow up | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the reduction in halitosis over 6 weeks using a questionnaire. (based on the perception of the subject). Timepoint: At Week 6 a questionaire will be given to the patient i.e at 3rd follow up;To measure improvements in gingival health as assessed by Gingival Index scores.Timepoint: At Week 6 gingival scores will be taken again i.e at 3rd follow up;To analyze microbial balance shifts that reduce harmful bacterial strains like Streptococcus mutans and Lactobacillus acidophilusTimepoint: At Week 6 Last microbiota sampling will be done i.e at 3rd follow up | — |
Countries
India
Contacts
Indian Dental Association